| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/13/2004 | US6676942 Undergoes polymerase chain reaction with primers prospa1-a4 but not prospa1-a2 |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/13/2004 | US6676940 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/13/2004 | CA2000498C Osteogenic factors |
| 01/08/2004 | WO2004003555A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 01/08/2004 | WO2004003550A2 Individualization of therapy with anticoagulants |
| 01/08/2004 | WO2004003544A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/08/2004 | WO2004003211A1 Bispecific antibodies that bind to vegf receptors |
| 01/08/2004 | WO2004003206A1 Novel transglucuronidases and genes tehreof |
| 01/08/2004 | WO2004003196A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| 01/08/2004 | WO2004003193A1 Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof |
| 01/08/2004 | WO2004003183A1 Immunoliposome conjugated with anti-upa antibody |
| 01/08/2004 | WO2004003179A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003160A2 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 01/08/2004 | WO2004003158A2 Methods and compositions for modulating and detecting wisp activity |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003155A2 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors |
| 01/08/2004 | WO2004003144A2 Antibodies that specifically bind to reg iv |
| 01/08/2004 | WO2004003141A2 A protein that interacts with lipids and methods for treating hyperlipidemia |
| 01/08/2004 | WO2004003021A1 HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION |
| 01/08/2004 | WO2004003020A1 Method of detecting perilymphatic fistula |
| 01/08/2004 | WO2004003019A2 Immunoglobin single variant antigen-binding domains and dual-specific constructs |
| 01/08/2004 | WO2004002529A1 Supplemented antibody in circulating system of newborns |
| 01/08/2004 | WO2004002528A1 Compositions and methods for therapeutic treatment |
| 01/08/2004 | WO2004002527A1 Compositions against chicken coccidiosis |
| 01/08/2004 | WO2004002526A1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/08/2004 | WO2004002525A1 Use of antibodies against flt-1 for the treatment of osteoporosis |
| 01/08/2004 | WO2004002524A1 Placental growth factor as a target for the treatment of osteoporosis |
| 01/08/2004 | WO2004002500A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 01/08/2004 | WO2004002427A2 Methods for the treatment or prevention of obesity |
| 01/08/2004 | WO2004002425A2 Process for promoting graft acceptance by depletion of hematopoietic stem cells |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002421A2 Method for the treatment of multiple sclerosis |
| 01/08/2004 | WO2004002417A2 Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003093315A3 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003089611A3 ANTIBODIES FOR ENZYMES OF THE ω-OXIDATION PATHWAY AND METHODS RELATING THERETO |
| 01/08/2004 | WO2003085093A3 Antibodies that specifically bind to gmad |
| 01/08/2004 | WO2003080665A3 Antibody that binds to a dimer of a prion protein for the treatment of tse infection |
| 01/08/2004 | WO2003076471A3 A multifunctional complex for targeting specific phagocytosis of a target agent |
| 01/08/2004 | WO2003075844A3 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002066053A3 Method of treating or preventing disease characterized by cryptococcus neoformans infection |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002055697A3 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002050250A3 Signal-1/signal-2 bifunctional peptide inhibitors |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006776 Transgenic production of antibodies in milk |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006216 Comprises immunoglobulin for treating cancer; immunosuppressant; immunotherapy |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040006213 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use |
| 01/08/2004 | US20040006212 Antibody and antibody fragments for inhibiting the growth of tumors |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006209 Comprises immunoglobulin which specifically binds staphylococcal g-protein and receptor sites for preventing and treating infections; gentic vaccines |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006006 Polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the |
| 01/08/2004 | US20040005671 Immunointeractive molecules |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005649 Monoclonal antibody for monitoring and treating changes in tumor growth or metastasis |
| 01/08/2004 | US20040005648 PYK2 related products and methods |
| 01/08/2004 | US20040005647 Comprises monocolnal antibody for diagnosis and treatment of cancer; antitumor agents; tumor imaging |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005642 Comprises expression vectors coding antiproliferative agents; antisense agents; tumor diagnosis and treatment |
| 01/08/2004 | US20040005638 Determining concentration of target antibodies in mixtures; food analysis; disease diagnosis |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005589 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005578 Myocardial cell proliferation-associated genes |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005571 Axs gene and protein and methods related thereto |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005554 Novel glycoproteins and methods of use thereof |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005550 Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3 |
| 01/08/2004 | US20040005548 Anti-HIV1 antibodies |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005544 Comprise RNA viruses for diagnosis, prevention and treatment of repiratory system disorders; vaccine development; viricides; antisense therapy |
| 01/08/2004 | US20040005538 Crystalline human CR2 protein in complex with C3d, and the three dimensional structure of the crystalline complex. Also disclosed are methods of use of the structure, particularly for structure-based identification of compounds that bind to |
| 01/08/2004 | US20040005334 Redirection of cellular immunity by receptor chimeras |
| 01/08/2004 | US20040005333 Recombinant gene fusion encoding a human IgG1 heavy chain constant region and a single-chain variable fragment antibody of 1A4A1 monoclonal antibody is disclosed. The recombinant antibody of the present invention confers human immune |
| 01/08/2004 | US20040005331 Polypeptides and fragments of polypeptides containing histidine triad residues or coiled-coil regions, some of which polypeptides or fragments lie between 80 and 680 residues in length. Also disclosed are processes for |